Cancer research has been waging war against cancer for many years. Cancer is one of the most frustrating and deadly diseases to ever come into fruition. The disease can ravage the vital organs of the body, which can play a major role in causing death. Cancer treatments of the past were very harsh on the human body and amputations were very common to stop the spread of the disease. One of the biggest names in this exclusive industry is Dr. Clay Siegall, and he has helped to revolutionize the industry in more ways than one.
With a Ph.D in Genetics from George Washington University and a B.S. in Zoology from the University of Maryland, Dr. Siegall is more than qualified for the task at hand. This extraordinary man is also the founder for one of the world’s leading cancer-research organizations. This organization is known as Seattle Genetics, and it is at the apex of the industry. ADCETRIS, the company’s flagship drug, has helped to generate more than $350 million in revenue. Dr. Siegall has played a key role in the success of this particular drug. Dr. Siegall was able to enter the drug into multiple licensing deals with top pharmaceutical-drug companies. By entering the drug into these deals, ADCETRIS can now be distributed and used in foreign markets. These foreign markets consist of up to 65 countries. ACDETRIS has helped Seattle Genetics move to the forefront of cancer research.
Dr. Siegall has a first-hand account of dealing with cancer, which is what drove him to become such a major figure. His father struggled with the disease for quite some time. This is what lit the actual fire under Siegall, and he has been working diligently to fight this dangerous disease. All in all, Dr. Clay Siegall is an American icon in cancer research, but who knows what’s in store in the years to come.